...
首页> 外文期刊>Journal of substance abuse treatment >Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women A report from the Women's Interagency HIV Study.
【24h】

Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women A report from the Women's Interagency HIV Study.

机译:药物治疗对妇女间艾滋病毒研究中的一份报告的多立体群组中随后性风险行为的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The evidence that drug treatment programs are associated with changes in sexual behavior and, thus, have prevention benefits beyond addiction is inconclusive. We examined whether entry into drug treatment was associated with subsequent alterations in sexual behavior among a group of drug-using women. METHODS: Data were collected semiannually via structured interviews over 8 years. Generalized estimating equations evaluated the relationship between self-reported drug treatment at each visit and sexual abstinence and consistent condom use in the subsequent 6-month period. RESULTS: In this sample (N = 1,658; mean age, 37.3 years; 57.5% African American; 80.3% HIV positive; 49.6% crack/cocaine users), 40% reported being in a variety of drug treatment programs. Those undergoing drug treatment (vs. those not) were less likely to become sexually active (adjusted odds ratio [AOR], 0.83; 95% confidence interval [CI], 0.76-0.91); this association was unchanged when the frequency of attendance and number of different drug treatment programs were evaluated. Drug treatment was not associated with subsequent consistent condom, regardless of frequency of attendance, but involvement in at least three treatment programs was (AOR, 1.40; 95% CI, 1.00-1.97). CONCLUSIONS: Additional efforts are needed to integrate effective sexual risk reduction programs into drug treatment settings; expanding access to different types of drug treatment modalities may be indicated.
机译:背景:药物治疗方案与性行为变化有关的证据,因此,预防额外的益处是不确定的。我们研究了是否进入药物治疗与一组药物妇女的后续性行为的改变有关。方法:通过8年来通过结构化访谈学习数据。广义估计方程评估了自我报告的药物治疗在每次参观和性禁欲之间的关系,在随后的6个月内使用了一致的避孕套。结果:在该样品中(n = 1,658;平均年龄,37.3岁; 57.5%非洲裔美国人; 80.3%HIV阳性; 49.6%裂缝/可卡因用户),报告有40%的药物治疗方案。那些经历药物治疗(与那些没有)的人不太可能变得性活跃(调整的赔率比[AOR],0.83; 95%置信区间[CI],0.76-0.91);当评估不同药物治疗方案的出勤率和数量的频率时,这种关联不变。无论出席频率,药物治疗与随后的一致避孕套无关,但参与至少三个治疗方案是(AOR,1.40; 95%CI,1.00-1.97)。结论:需要额外的努力将有效的性风险减少计划整合到药物治疗环境中;可以指出扩展对不同类型的药物治疗方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号